IP Library Granted Patent US 9,228,146
Granted Patent B2
US 9,228,146 · App. 14/613,311 · Granted Jan 5, 2016

High- and low-viscosity estolide base oils and lubricants

Inventor: Jakob Bredsguard (Lake Forest, CA)
Assignee: Biosynthetic Technologies, LLC
C10M105/34C07C57/02C07C67/465C07C67/48C07C67/54C07C69/34C07C69/604C07C69/675C10M105/36C10M107/32C11C3/00C11C3/003C11C3/08C10M2207/2825C10M2209/1023C10N2220/022C10N2220/023C10N2220/027C10N2220/028C10N2220/10C10N2230/02C10N2230/64
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,228,146
App. No.
14/613,311
Granted
Jan 5, 2016
Kind
B2
Abstract

Provided herein are compounds of the formula: in which n is an integer equal to or greater than 1; R 2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and R 1 , R 3 , and R 4 , independently for each occurrence, are selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched, wherein compositions comprising the compounds are characterized by particular combinations of values for estolide number, kinematic viscosity, and pour point. Also provided are compositions containing the compounds and methods of making both the compounds and compositions thereof.

Claims (30)

1. A composition consisting essentially of at least one estolide compound, said composition having:

an EN that is an integer or fraction of an integer selected from 1.0 to 1.6, wherein the EN is the average number of estolide linkages in compounds according to Formula I; and

a kinematic viscosity of about 4 cSt to about 10 cSt when measured at 100° C.,

wherein said at least one estolide compound is selected from compounds of Formula I:

wherein

x is, independently for each occurrence, an integer selected from 7 and 8;

y is, independently for each occurrence, an integer selected from 0, 1, and 2;

n is an integer selected from 0 to 4;

R 1 is an unsubstituted C 7 to C 17 alkyl that is saturated and branched or unbranched; and

R 2 is an unsubstituted C 1 to C 18 alkyl that is saturated or unsaturated, and branched or unbranched,

wherein each fatty acid chain residue of said at least one estolide compound is unsubstituted.

2. The composition according to claim 1 , wherein x+y is 7 for each fatty acid chain residue.

3. The composition according to claim 1 , wherein x+y is 8 for each fatty acid chain residue.

4. The composition according to claim 1 , wherein R 2 is selected from methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decanyl, undecanyl, dodecanyl, tridecanyl, tetradecanyl, pentadecanyl, hexadecanyl, heptadecanyl, and octadecanyl, which are saturated and branched or unbranched.

5. The composition according to claim 1 , wherein R 2 is selected from C 6 to C 12 alkyl that is branched.

6. The composition according to claim 5 , wherein R 2 is 2-ethylhexyl.

7. The composition according to claim 1 , wherein R 1 is selected from C 7 alkyl that is saturated and unbranched.

8. The composition according to claim 1 , wherein R 1 is selected from C 9 alkyl that is saturated and unbranched.

9. The composition according to claim 1 , wherein R 1 is selected from C 10 alkyl that is saturated and unbranched.

10. The composition according to claim 1 , wherein said composition has a kinematic viscosity of about 15 cSt when measured at 40° C.

11. The composition according to claim 1 , wherein said composition has a kinematic viscosity of about 16 cSt when measured at 40° C.

12. The composition according to claim 1 , wherein said composition exhibits an iodine value (IV) of less than 10 cg/g.

13. The composition according to claim 10 , wherein said composition exhibits an iodine value (IV) of less than 5 cg/g.

14. The composition according to claim 1 , wherein said at least one estolide compound is derived from a process that comprises forming a covalent bond between an oxygen of a carboxylic group of at least one first fatty acid and a carbon of at least one site of unsaturation of at least one second fatty acid.

15. The composition according to claim 2 , wherein R 1 is selected from C 9 alkyl that is saturated and unbranched.

16. The composition according to claim 15 , wherein said composition has a kinematic viscosity of about 15 cSt when measured at 40° C.

17. The composition according to claim 3 , wherein R 1 is selected from C 10 alkyl that is saturated and unbranched.

18. The composition according to claim 17 , wherein said composition has a kinematic viscosity of about 16 cSt when measured at 40° C.

19. The composition according to claim 1 , wherein said composition exhibits a pour point of less than −50° C.

20. The composition according to claim 1 , wherein said composition exhibits a pour point of −50° C. to −60° C.

Assignments (6)
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: EVONIK OIL ADDITIVES USA, INC.
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045684/0293 →
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: BP TECHNOLOGY VENTURES INC.
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045688/0600 →
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: EVONIK CORPORATION
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045860/0547 →
SECURITY INTEREST Recorded Jan 30, 2018
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: BP TECHNOLOGY VENTURES INC.
Reel/Frame 045196/0587 →
SECURITY INTEREST Recorded Mar 18, 2016
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: EVONIK OIL ADDITIVES USA, INC.
Reel/Frame 038146/0859 →
SECURITY INTEREST Recorded Nov 30, 2015
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: EVONIK CORPORATION
Reel/Frame 037162/0364 →
Continuity (6)
Continuation 13865495 · Apr 18, 2013
Continuation 13711388 · Dec 11, 2012
Continuation 13199554 · Aug 31, 2011
Provisional Application 61498499 · Jun 17, 2011
Provisional Application 61378891 · Aug 31, 2010
Related Publication 20150210950A1 · Jul 30, 2015